Cardiovascular effects of tyramine: Adrenergic and cholinergic interactions

European Journal of Pharmacology

Volumn 579, Issue 1-3, 2008, Pages 308-317

  Khwanchuea, Rapheeporn ^a   Mulvany, Michael J ^b   Jansakul, Chaweewan ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Atenolol; Atropine; Blood pressure; Heart rate; Propranolol; Tyramine

Indexed keywords

ATENOLOL; ATROPINE; ISOPRENALINE; MUSCARINIC RECEPTOR BLOCKING AGENT; N(G) NITROARGININE; PHENTOLAMINE; PRAZOSIN; PROPRANOLOL; RESERPINE; TYRAMINE; YOHIMBINE;

ADRENERGIC ACTIVITY; ANIMAL TISSUE; ARTICLE; CHOLINERGIC ACTIVITY; CHRONOTROPISM; DRUG POTENTIATION; ENDOTHELIUM; FEMALE; HEART ATRIUM; HEART RATE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; VAGUS NERVE STIMULATION; VASCULAR RING;

ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; AORTA, THORACIC; BLOOD PRESSURE; CATECHOLAMINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FEMALE; HEART RATE; PARASYMPATHOLYTICS; RATS; RATS, WISTAR; SYMPATHOMIMETICS; TYRAMINE;

EID: 37549067428     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.10.029     Document Type: Article

References (30)

1. Agon P., Goethals P., Van Haver D., and Kaufman J.M. Permeability of the blood-brain barrier for atenolol studied by positron emission tomography. J. Pharm. Pharmacol. 43 (1991) 597-600
2. Benfey B.G., and Varma D.R. Inhibition of sympathomimetic effects on the heart. Br. J. Pharmacol. 23 (1964) 399-404
3. Bieck P.R. Hypertensive crises with reversible inhibitors of monoamine oxidases? Results of tyramine interaction studies. Psychiatr. Prax. 16 (1989) 25-31 Suppl
4. Bieck P.R., and Antonin K.H. Oral tyramine pressor test and the safety of monoamine oxidase inhibitor drugs: comparison of brofaromine and tranylcypromine in healthy subjects. J. Clin. Psychopharmacol. 8 (1988) 237-245
5. Black J.W., Jenkinson D.H., and Kenakin T.P. Antagonism of an indirectly acting agonist: block by propranolol and sotalol of the action of tyramine on rat heart. Eur. J. Pharmacol. 65 (1980) 1-10
6. Brown C., Taniguchi G., and Yip K. The monoamine oxidase inhibitor-tyramine interaction. J. Clin. Pharmacol. 29 (1989) 529-532
7. Chandra O., Dhawan K.N., and Gupta G.P. Release of acetylcholine by tyramine. Arch. Int. Pharmacodyn. 157 (1965) 141-147
8. Euler D.E. Release of autonomic neuromediators by local ventricular electrical stimulation. Am. J. Physiol. 238 (1980) H794-H800
9. 1-adrenoceptor activation can increase heart rate directly or decrease it indirectly through parasympathetic activation. Br. J. Pharmacol. 77 (1982) 319-328
10. Goto K., Ishikawa T., Kimura S., and Saito A. Intramural nerve-mediated inotropic responses of left atria of rats and guinea pigs: demonstration of alpha adrenergic and nonadrenergic noncholinergic responses on guinea pigs. J. Pharmacol. Exp. Ther. 243 (1987) 723-730
11. th ed. (2001), McGraw-Hill, Medical Publishing Division, New York 220-221
12. Jacob G., Costa F., Vincent S., Robertson D., and Biaggion I. Neurovascular dissociation with paradoxical forearm vasodilatation during systemic tyramine administration. Circulation 107 (2003) 2475-2479
13. Jansakul C., Boura A.L., and King R.G. Effects of endothelial cell removal on constrictor and dilator responses of aortae of pregnant rats. J. Auto. Pharmacol. 9 (1989) 93-101
14. Khwanchuea, R., 2006. Cardiovascular effects of crude extract and substance(s) isolated from fresh fruits of Randia siamensis. Ph.D thesis. Biomedical Science Ph.D Program, Graduate school, Prince of Songkla University, Hat-Yai, Thailand, pp. 85.
15. Liu X., Smith B.J., Chen C., et al. Evaluation of cerebrospinal fluid concentration and plasma free concentration as a surrogate measurement for brain free concentration. Drug Metab. Dispos. 34 (2006) 1443-1447
16. Mahon W.A., and Mashford M.L. The pressor effect of tyramine in man and its modification by reserpine pretreatment. J. Clin. Inves. 42 (1963) 338-345
17. McCulloch J., Deshmukh V.D., and Harper A.M. Indirect sympathetic agents and cerebral blood flow and metabolism. Eur. J. Pharmacol. 47 (1978) 11-18
18. Meck J.V., Martin D.S., D'Aunno D.S., and Waters W.W. Pressor response to intravenous tyramine is a marker of cardiac, but not vascular, adrenergic function. J. Cardiovasc. Pharmacol. 41 (2003) 126-131
19. Mundorf M.L., Hochstetler S.E., and Wightman R.M. Amine weak bases disrupt vesicular storage and promote exocytosis in chromaffin cells. J. Neurochem. 73 (1999) 2397-2405
20. Pardini B.J., Lund D.D., and Schmid P.G. Contrasting preganglionic and postganglionic effects of phenylephrine on parasympathetic control of heart rate. Am. J. Physiol. 260 (1991) H118-H122
21. Paterson I.A., Juorio A.V., and Boulton A.A. 2-Phenylethylamine: a modulator of catecholamine transmission in the mammalian central nervous system?. J. Neurochem. 55 (1990) 1827-1837
22. Poller U., Schafers R.F., Schmuck S., Jakubetz J., Radke J., Daul A.E., Ponicke K., and Brodde O.E. Influence of atropine on the cardiovascular effects of noradrenaline and tyramine in elder volunteers. Naunyn-Schmiedeberg's Arch. Pharmacol. 356 (1997) 100-106
23. Rice P.J., Taylor D.A., Valinsky W.A., Head R.J., and Fleming W.W. Norepinephrine depletion and sensitivity changes in rat heart induced by pretreatment with reserpine. J. Pharmacol. Exp. Ther. 240 (1987) 764-771
24. Schafers R.F., Poller U., Ponicke K., Geissler M., Daul A.E., Michel M.C., and Brodde O.-E. Influence of adrenoceptor and muscarinic receptor blockade on the cardiovascular effects of exogenous noradrenaline and of endogenous noradrenaline released by infused tyramine. Naunyn. Schmiedeberg's Arch. Pharmacol. 355 (1997) 239-249
25. Schonfeld C.L., and Trendelenburg U. The release of 3H-noradrenaline by p- and m-tyramines and -octopamines, and the effect of deuterium substitution in alpha-position. Naunyn. Schmiedeberg's Arch. Pharmacol. 339 (1989) 433-440
26. Taesotikul T., Panthong A., Kanjanapothi D., Verpoorte R., and Scheffer J.J.C. Cardiovascular activity of the crude alkaloid fraction from Tabernaemontana pandacaqui in the rat. J. Ethnopharmacol. 59 (1998) 131-137
27. Tallman J.F., Saavedra J.M., and Axelrod J. Biosynthesis and metabolism of endogenous tyramine and its normal presence in sympathetic nerves. J. Pharmacol. Exp. Ther. 199 (1976) 216-221
28. Thompson E.B., and West T.C. Antagonism by propranolol of the cardiac chronotropic response to norepinephrine or to transmural electrical stimulation. J. Pharmacol. Exp. Ther. 161 (1968) 232-237
29. Van Zwieten P.A., and Timmermanns P.B. Brain levels and acute antihypertensive activity of beta-blockers. Eur. J. Clin. Pharmacol. 28 (1985) 13-19
30. 1-adrenergic receptor. Circ. Res. 56 (1985) 763-766